| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
529 |
437 |
$22K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
186 |
177 |
$6K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
173 |
165 |
$6K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
494 |
405 |
$5K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
449 |
358 |
$4K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
249 |
239 |
$2K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
50 |
49 |
$2K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
59 |
59 |
$1K |
| 87340 |
|
116 |
111 |
$1K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
40 |
40 |
$1K |
| 86762 |
|
101 |
98 |
$951.56 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
121 |
116 |
$891.88 |
| 84702 |
|
86 |
70 |
$757.51 |
| 86592 |
|
118 |
112 |
$451.61 |
| 36415 |
Collection of venous blood by venipuncture |
440 |
386 |
$190.52 |
| 87070 |
|
26 |
25 |
$176.36 |
| 81003 |
|
44 |
42 |
$104.20 |
| 99001 |
|
14 |
13 |
$0.00 |